The hardest part is waiting, these guys only put out a PR about once every 2 months and with the update yesterday it could be quite a while before we hear anything else ...
I was thinking it might hit a fresh multi year low on the "go it alone" strategy, I guess we need to wait another quarter or two and see the cash disappear before it gets thumped
Anyne watching for Mr. Dodd to turn into Mr. Nodd? You know the grin, the wink and gun, like he's just itching to tell someone what's up?
If Dodd really has multiple interested parties I wouldn't be surprised to see a buy out. Why would BIG PHARMA partner when we're trading at $3.00, bleow cash and with a $30 million cap, our NOL tax losses are worth hundreds of millions, just give us an offer for a decent price. Now is the best time to do it and BIG PHARMA knows that
I thought it was to win a Pulitzer prize in literature ... bullet points dude, bullet points!!! lol - idiot
the good news is when we are purchased for $25.00 / share we won't have to hear from blithering idiots like you again
cutugno, it would be insane for him to say they are aggressively seeking partners at this conference unless he had some meetings set up with definitive preliminary interest - more than one. Also, he knows coming out of this conference in the near term Investors will expect a follow up commentary so he will either have to say a deal was inked or they couldn't come to agreeable terms. I'm guessing within 30 days .... patience
If that's the case mort why not give shareholders a heads up? last we heard he was talking about seeing the data "clearly by year end". Obviously data is out of his control and it's up to the GOG if it's delayed. But why then not give shareholders an update? Missed anticipated milestones does not instill shareholder confidence. My guess is it's not definitive and he doesn't know what to tell the street.
Been keeping an eye on this bad girl for the right signal to buy back in, today not only didn't get a positive signa,,l I was left with a negative outlook for the near term. I'll track until they start FOCUS and if I still don't see what I'm looking for I'll pull it off my watchlist all together and conclude they need a new vision and whole sale Management change from the BOD down. This is a cruel joke at this point.
don't see this turning around at all in the next 6-8 months, in fact I see it deteriorating
How many years he worked for FDA, what Biologics he approved, what he did at Chelsea etc. What have you done for Oxigene? \Maybe he should focus on that, maybe tell us what the share price was when you arrived last May and what is it today, how much cash has burned on his watch, how the stock has slid out of Nasdaq compliance .... maybe that's what he should tell the audience at Investor Conferences.
no need whatsoever to go to this conference. they need to update shareholder on an inexpensive CC once in a while, maybe a webex if they have a potential partner. they only time they should be stepping on a plane is with lawyers to ink a deal in person after the terms have been worked out. prolly cost $20K to attend.
"And this slide speaks to our business development efforts, her we are partnered on X, this bullet point shows where we out licenced Y to company C. Further we are talking about acquiring B in the near term. Ultimately we would like to work with companies D and E to become their partners for Y. We hope to close deal F by x time and feel that upfront payments could see us through to profitability"
Seriously, where's the deal maker? Pay me just a measly $250,000 salary and I'll have a half dozen companies, offers and partnerships lined up within 6-8 months. Instead it's another cancelled or delayed project. What does Jeff Nelson VP of Programs do with my shareholder money?